by Admin | Feb 16, 2022 | Delos News
HONG KONG, Feb. 15, 2022 /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III....
by Admin | Sep 14, 2020 | Delos News, Portfolio News
BEDFORD, Mass., Sept. 14, 2020 /PRNewswire/ — Rejoni announced today that it has closed a $15 million Series A financing. The round was led by Ascension Ventures, with additional participation from Delos Capital and Sparta Group. Rejoni is using its...
by Admin | Dec 10, 2019 | Delos News
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s portfolio, which is composed of the latest advances in...
by Admin | Nov 27, 2019 | Delos News
CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced the completion of a US$ 43 million (RMB 304 million) Series B...
by Admin | Sep 20, 2019 | Delos News
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, with a $10 million Series A financing. Curamir...
by Admin | Jun 5, 2019 | Delos News
PHOENIX – June 5, 2019 – OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company founded on the myxoma virus (MYXV) platform from Arizona State University (ASU), announced today the completion of a $25 million series A financing led by Boehringer...